What You Should Know:
- Today, Phenomix Sciences announced the company has signed an exclusive technology licensing agreement with Mayo Clinic for a novel blood test that accurately predicts obesity phenotypes.
- The multi-level “omics” MyPhenome™ test leverages technology developed at Mayo Clinic to analyze genomics, metabolomics and hormone levels. Its AI-driven algorithmic solution identifies four specific obesity phenotypes to give doctors the ability to
Read More
Obesity
Could ‘Hospitals Without Walls’ Be the New Normal for Telehealth and Remote Patient Monitoring?
The statistics surrounding the COVID-19 pandemic continue to be startling, despite the ever-growing mental and physical fatigue that we’ve all experienced living through this frightening, intimidating and unprecedented era. More than 125 million cases worldwide have resulted in a death toll closing in on three million, while in the United States alone, 30 million reported infections have resulted in a death toll that reached 550,000. (1) One thing that can be said for certain about
Read More
How NLP Can Uncover Social Determinants of Heart Disease
Heart disease is the leading cause of death for people of most racial and ethnic groups in the United States. Cardiovascular disease-related deaths—which occur every 36 seconds—cost our country about $219 billion each year, according to the Centers for Disease Control and Prevention (CDC). People with poor cardiovascular health are also at increased risk of severe illness from COVID-19, so the time to act is now. There’s no time like the present to look at major risk factors—from obesity and
Read More
Glooko Raises $30M to Expand Digital Diabetes Management Platform
What You Should Know:
- Glooko, a Palo Alto, CA-based provider of remote patient monitoring and chronic care management solutions including diabetes and obesity, today announced that they have raised a $30 million Series D round of funding. The funding was led by Health Catalyst Capital along with participation from existing investors Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic.
- Glooko plans to use these proceeds from this funding to accelerate organic growth and
Read More
Innovative, Non-Invasive Technologies Advanced Earlier Detection & Monitoring of Liver Disease
Leveraging technological advances to facilitate new ways of engaging patients and integrating non-invasive technology into a liver disease program not only serves to improve individual outcomes and reduce costs but also strengthens the financial performance of health systems and provider organizations that include this approach to testing.
At a time when America’s hospitals and physician groups face lost revenues due to the COVID-19 pandemic, there is a pressing need for reducing costs while
Read More
DarioHealth Acquires Musculoskeletal Solution Upright for $31M
What You Should Know:
- DarioHealth, a Livongo competitor acquires musculoskeletal startup Upright for $31 million to expand their chronic condition management capabilities focused on driving behavior change rather than treating the acute problem. This move will more than double revenue and create one of the largest integrated digital health companies in the space.
In addition, DarioHealth rasiess $70 million through a private placement of its common stock priced at the market pursuant to
Read More
Humana Taps Vida Health to Power Virtual Diabetes Management for Kentucky’s Medicaid Population
What You Should Know:
- Humana Healthy Horizons™ in Kentucky announced it has selected Vida Health’s virtual diabetes management program to serve Kentucky’s Medicaid population.
- Vida’s diabetes management program
achieves lasting results for participants. Because chronic conditions like diabetes,
obesity, and hypertension often occur simultaneously, Vida’s unique program was
built from the ground up to treat multiple conditions at the same time.
- The new partnership, which will
Read More
Digital Diabetes Market to Reach $1.5B by 2024, Research Finds
What You Should Know:
- The digital diabetes market is on track to reach $1.5
billion dollars by 2024, according to a new report by Research2Guidance.
- The confident growth of digital diabetes care will be driven by the growth of the global addressable market for digital diabetes services. Between 2019 and 2024, the number of diagnosed diabetics with access to smart devices is set to increase from 109 million to 180 million.
- Digital diabetes solutions have disrupted the
Read More
How Care Coordination Technology Addresses Social Isolation in Seniors
Senior isolation is a health risk that affects at least a quarter of seniors over 65. It has become recognized over the past decade as a risk factor for poor aging outcomes including cognitive decline, depression, anxiety, Alzheimer’s disease, obesity, hypertension, heart disease, impaired immune function, and even death.
Physical limitations, lack of transportation, and inadequate health literacy, among other social determinants of health (SDOH), further impair access to medical and mental
Read More
Is Remote-Learning A Public Health Dilemma?
In 2014, pediatric occupational therapist Angela Hanscom set out to better understand the student experience by sitting in on middle school classes. She sat. She sat some more. She then noticed that a day’s worth of sitting was affecting her ability to focus. She asked “how on Earth do these children tolerate sitting this long?” before spotting all the fidgety, distracted bodies – “well, the short answer is they don’t.”
This phenomenon is rooted in the commonly ignored factor that students
Read More
